Bausch Health and YUN Expand Their Strategic Partnership in EMEA and Mexico

In a landmark announcement, Bausch Health Companies Inc. and YUN have unveiled plans to expand their collaborative efforts into Mexico and several key markets within the EMEA region. This strategic partnership aims to enhance access to scientifically-backed skincare solutions that are gentle on the microbiome, improving the lives of consumers and patients alike.

The collaborative expansion follows Bausch Health's successful introduction of YUN’s probiotic-based skincare products in Poland throughout 2025. The venture focuses on adding to its existing portfolio with YUN’s innovative products tailored for eczema and acne-prone skin. Currently, the collaboration has broadened its geographical reach, with offerings now available in the Czech Republic, Slovakia, Ukraine, Bulgaria, and Mexico. Plans for further market penetration are set, with Kazakhstan projected to join the initiative by October 2026.

Cees Heiman, Senior Vice President for Europe and Canada at Bausch Health, expressed the company's commitment to delivering differentiated healthcare products across the EMEA region, emphasizing the potential for YUN's microbiome-focused approach in various markets. "The EMEA region is strategically vital for Bausch Health, and we anticipate strong growth opportunities in Ukraine, Bulgaria, the Czech Republic, Slovakia, and Kazakhstan, thanks to our partnership with YUN," he stated.

Fernando Zarate, Vice President for Latin America at Bausch Health, highlighted the significance of this expansion into Mexico, which injects new life into their portfolio of dermatological solutions. Zarate noted that this endeavor reflects the company's dedication to addressing the evolving skincare needs of consumers while increasing access to groundbreaking dermatological innovations in Mexico.

"We take pride in deepening our collaboration with Bausch Health as YUN enters into further international markets," said Tom Verlinden, CEO and Founder of YUN, underlining their mission to leverage microbiome science through their YUN Probiotherapy™ technology. This patented platform enables stable use of live probiotics in skincare products designed to support the skin’s natural ecosystem. Through this partnership, Bausch Health and YUN aim to enhance their brand presence across Mexico and select EMEA markets while improving access to innovative probiotherapeutic skincare solutions.

YUN, a pioneering Belgian biotechnology company established in 2016, combines live probiotics with prebiotics and postbiotics into products designed to be microbiome-friendly. This approach ensures that their offerings respect and enhance the skin's natural microbiome while providing effective solutions for dermatological, oral, pediatric, intimate, and ear care needs. YUN’s commitment to bringing science-backed, natural solutions to consumers is set to benefit not only the present generation but also future ones.

Bausch Health, publicly traded on both NYSE and TSX as BHC, is committed to enriching the lives of patients globally through its diverse range of healthcare products across various fields, including gastroenterology, neurology, dermatology, and eye health. The company strives to be recognized as a trusted and valued healthcare partner by patients, healthcare professionals, employees, and investors.

In conclusion, the ongoing expansion in EMEA and into Mexico signifies a critical growth phase for both Bausch Health and YUN, creating new opportunities for innovative skincare solutions and enhancing the accessibility of essential dermatological products for consumers in these regions. As they continue to push boundaries in microbiome-friendly skincare, both companies are set to make a significant impact on the health and wellness landscape in new and diverse markets.